Fishawack Group Acquires Healthcircle to Strengthen Creative Offering
The Fishawack Group of Companies, one of the world’s largest independent medical communications organisations, has acquired Healthcircle Advertising Limited, a strategic brand communications agency with offices in London and Portugal.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180709005905/en/
Top row: Dominic Miller, Fishawack COO, Gail Flockhart, Fishawack Managing Partner, Liz Maclaren, Healthcircle Creative Director, Dr. David Ingram, Healthcircle Managing Partner; Bottom row: Mike Taylor, Healthcircle Managing Director, Oliver Dennis, Fishawack CEO (Photo: Business Wire)
“This acquisition is a major step in Fishawack’s plan to build a global strategic creative agency that can work alongside our medical communications business,” explained Oliver Dennis, Chief Executive Officer of the Fishawack Group. “We also acquired US-based Carling Communications in July last year. Carling needed critical mass in Europe and Healthcircle needed a US partner. This is a great match and positions us to deliver integrated creative and medcomms solutions for clients on a truly global scale.”
Mike Taylor, Managing Director of Healthcircle added, “We’ve been on the lookout for a partner to support our growth in the US whilst also providing us access to scientific and strategic talent. Healthcircle and Fishawack have already collaborated extensively and we’ve known and worked with many of the Carling team over our years in the business.”
Gail Flockhart, Group Managing Director at Fishawack said, “All agencies are collections of people with different talents. What makes us different is the investment we make in establishing real chemistry between teams so that collaboration is fun and triggers new ideas. We’re still at a size where we can make this meaningful.”
About the Fishawack Group
The Fishawack Group of Companies is one of the largest independent medical communications specialists, with offices in the UK (Knutsford, Oxford, and Brighton), the USA (Philadelphia, PA, and San Diego, CA), Switzerland (Basel), and India (Hyderabad).
For over 17 years, Fishawack has been partnering with global and regional pharmaceutical, biotechnology, and medical device clients to develop and deliver services in the fields of medical communications, scientific engagement, market access, strategic consultancy, and thought leader consultancy. For more detailed information about our services, please see the Fishawack Group website at www.fishawack.com.
We have built our reputation on excellence, creativity, and transparency.
About Healthcircle
Healthcircle is a full-service strategic brand communications agency. With extensive experience in direct-to-patient communications, creative digital solutions and creative medcomms, Healthcircle has consistently won awards for its surprising and innovative creative work. Healthcircle is headquartered in London, UK, with an office in Cascais, Portugal.
Healthcircle strongly believes that connecting strategy and creative is the key to brand success and has demonstrated the success of this approach on some of the largest brands in the global pharmaceutical marketplace during the last 10 years. More information is available at www.healthcircle-uk.com
Fishawack Group of Companies
www.fishawack.com
Twitter:
@Fishawack
LinkedIn:
Fishawack Group of Companies
Headquarters:
100–102 King Street, Knutsford, Cheshire, WA16 6HQ, UK
Tel: +44
1565 756600
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180709005905/en/
Contact information
The Fishawack Group
Gail Flockhart
Group
Managing Director
gail.flockhart@fishawack.com
or
Healthcircle
Advertising Ltd
Mike Taylor
Managing Director
Mike.taylor@Healthcircle-uk.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Celltrion receives positive CHMP Opinion for SteQeyma™ (ustekinumab biosimilar) autoinjector18.12.2025 04:41:00 EET | Press release
Celltrion, Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion of autoinjector of SteQeyma™, a biosimilar to Stelara® (ustekinumab), for the treatment of plaque psoriasis, psoriatic arthritis (PsA) and Crohn’s disease (CD). The positive CHMP opinion is for SteQeyma autoinjector in 45mg/0.5mL and 90mg/1mL, expanding the currently approved SteQeyma™ presentation, which includes 45mg/0.5mL, 90mg/1mL in a pre-filled syringe and 45mg/0.5mL in a vial for subcutaneous injection, as well as 130mg/26mL concentrate for solution for intravenous infusion. “The new SteQeyma™ autoinjector brings together convenience and practical usability to meet the everyday challenges faced by patients living with chronic inflammatory diseases. The full range of our SteQeyma™ dosage forms and strengths, with the autoinjector now added, provides patients and healthcare professionals with more individualized treatm
Megaport Expands into India, Accelerating Global Growth with Extreme IX Acquisition18.12.2025 03:15:00 EET | Press release
Megaport Limited (ASX: MP1) (“Megaport”), the world’s leading Network as a Service (NaaS) provider, today announced the acquisition of Extreme IX,India’s leading Internet Exchange operator, from Extreme Labs, a Bulgaria-headquartered software and network engineering company that incubated the Extreme IX platform. The acquisition expands Megaport’s global platform into one of the world’s fastest-growing digital infrastructure markets and supports the Company’s strategy to deliver scalable, high-performance connectivity services across APAC. The acquisition establishes Megaport’s presence across seven Internet Exchanges in major Indian metros: Delhi, Kolkata, Hyderabad, Chennai, Bengaluru, Mumbai, and Pune, connecting 40+ data centres and more than 400 customers. It also accelerates Megaport’s planned market entry by nearly three years, while adding a seasoned in-country team spanning operations, support, sales, finance, and leadership to enable rapid integration and future growth. The E
IonQ and QuantumBasel Expand Long-Term Partnership in Next-Generation Quantum Systems17.12.2025 23:10:00 EET | Press release
IonQ (NYSE: IONQ), the world’s leading quantum company, today announced an expanded agreement with QuantumBasel, the quantum initiative of uptownBasel, Switzerland’s innovation campus. The extended contract grants QuantumBasel ownership of its existing IonQ Forte Enterprise system and secures ownership of a next-generation Tempo system. This new agreement brings the total deal value of the QuantumBasel and IonQ partnership to over $60 million and extends IonQ’s on-site presence in Switzerland four more years, continuing through 2029. QuantumBasel is IonQ’s official Innovation Center in Europe, serving as a hub for European industry, academia, and research institutions to explore practical quantum computing applications and access IonQ’s latest enterprise-grade systems. “Our extended partnership with QuantumBasel represents a cornerstone of IonQ’s global strategy,” said Niccolo de Masi, Chairman and CEO of IonQ. “QuantumBasel continues to be a critical innovation node for our company as
Suzano Starts Up New Production Line, Boosting Its Fluff Pulp Capacity by 400%17.12.2025 22:50:00 EET | Press release
Suzano, the world’s largest pulp producer, has commenced operations this week at its new fluff pulp production line located in its Limeira unit in Brazil’s São Paulo state. This R$490 million investment increases Suzano’s total fluff pulp production capacity by more than 400%, from 100,000 to 440,000 tonnes per year. The project involved converting the existing pulp line at the Limeira unit into a flexible machine, capable of producing both Eucafluff® and market pulp. Eucafluff® is used in the production of absorbent and personal hygiene products, such as baby and adult diapers, sanitary pads and pet pads. Then market pulp is supplied for making products including toilet paper, printing and writing papers, and paper packaging. Launched in 2015, Eucafluff® is the world’s first fluff pulp made from eucalyptus, delivering unique advantages like enhanced softness and flexibility, which translate into thinner, more discreet and comfortable products. Its high compression capability enables s
SES Acknowledges Moody’s Rating Action and Reiterates Deleveraging Commitments17.12.2025 22:36:00 EET | Press release
SES S.A. (“SES” or the “Company”), a leading space solutions company, acknowledges the credit rating action announced by Moody’s Investor Service today, which follows the release of SES’ Q3 2025 results and Intelsat integration update. SES management reiterates that the Company continues to execute on its strategy with a clear plan to strengthen its key credit metrics over time. Consistent with this plan, it remains management’s intention to de-lever and return to credit metrics that are commensurate with investment grade, with a policy objective of reducing adjusted net leverage1 to at least 3.0x or below. Today’s rating action does not change the Company’s ability to operate its business, serve customers, or execute its strategic plan. SES maintains a balanced weighted average debt maturity profile of approximately five years, and the rating action from Moody’s is not expected to have a material impact on the interest payable under the Company’s existing debt facilities. SES also ben
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom